| Dr Paul Brooks Gaudin, MD | |
|
3445 Executive Center Dr, Suite 250, Austin, TX 78731-1678 | |
| (512) 579-4000 | |
| (512) 439-2814 |
| Full Name | Dr Paul Brooks Gaudin |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 3445 Executive Center Dr, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134180672 | NPI | - | NPPES |
| 1618753 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | K9278 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Seton Medical Center Austin | Austin, TX | Hospital |
| Seton Smithville Regional Hospital | Smithville, TX | Hospital |
| Seton Northwest Hospital | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hurt, Jacknow, Moore, Connor, Wells, Michels, Yurco, Listrom And Huang | 7113942798 | 44 |
News Archive
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).
Taking part in group psychotherapy can help men who have erectile dysfunction to over come their problem, and adding sildenafil to group therapy was more effective that sildenafil alone.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
More than 15 years ago Edward Stricker and Joseph Verbalis reported that oxytocin (OT) is involved in the neural control of food and salt intake in adult rats. Linda Rinaman at the University of Pittsburgh is investigating the anatomical organization of this system, and also is taking a developmental approach to determine how OT modulates eating and digestion.
› Verified 1 days ago
| Entity Name | Hurt, Jacknow, Moore, Connor, Wells, Michels, Yurco, Listrom & Huang |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255395810 PECOS PAC ID: 7113942798 Enrollment ID: O20051012000931 |
News Archive
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).
Taking part in group psychotherapy can help men who have erectile dysfunction to over come their problem, and adding sildenafil to group therapy was more effective that sildenafil alone.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
More than 15 years ago Edward Stricker and Joseph Verbalis reported that oxytocin (OT) is involved in the neural control of food and salt intake in adult rats. Linda Rinaman at the University of Pittsburgh is investigating the anatomical organization of this system, and also is taking a developmental approach to determine how OT modulates eating and digestion.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Brooks Gaudin, MD 3445 Executive Center Dr, Suite 250, Austin, TX 78731-1678 Ph: (512) 579-4000 | Dr Paul Brooks Gaudin, MD 3445 Executive Center Dr, Suite 250, Austin, TX 78731-1678 Ph: (512) 579-4000 |
News Archive
While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.
Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).
Taking part in group psychotherapy can help men who have erectile dysfunction to over come their problem, and adding sildenafil to group therapy was more effective that sildenafil alone.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study of laquinimod, an oral, once-daily, investigational immunomodulator for the treatment of relapsing forms of multiple sclerosis (MS). These data will be presented as late-breaking research at the Annual Meeting of the American Academy of Neurology (AAN).
More than 15 years ago Edward Stricker and Joseph Verbalis reported that oxytocin (OT) is involved in the neural control of food and salt intake in adult rats. Linda Rinaman at the University of Pittsburgh is investigating the anatomical organization of this system, and also is taking a developmental approach to determine how OT modulates eating and digestion.
› Verified 1 days ago
Dr. Joseph Howard Willman, MD Pathology Medicare: Medicare Enrolled Practice Location: 3445 Executive Center Dr, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Robert Domingo, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 12357 A Riata Trace Pkwy, Bldg 5, Ste 100, Thyroid Cytopathology Partners, Austin, TX 78727 Phone: 512-814-0298 Fax: 512-597-2713 | |
Christine Renee Burgess, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Grace Nightingale Cortez Jackson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Jared Dale Barker, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Dr., Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Vilmos A Thomazy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 12221 N Mopac Expressway, Namc Department Of Pathology, Austin, TX 78756 Phone: 512-901-1206 Fax: 512-901-1299 |